Trials / Completed
CompletedNCT04783350
Home-based Brain Stimulation for Memory
Home-based Transcranial Alternating Current Stimulation (tACS) for Older Adults at Risk of Memory Decline
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hebrew SeniorLife · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
The proposed project aims to systematically examine the feasibility of remote, caregiver-led tACS for older adults who are vulnerable to memory decline.
Detailed description
This is a feasibility study, which will include older adult participants (Ps) with memory deficits together with willing and able administrators (As) to administer tACS to the participants. This study will include 20 older Ps and 20 As to assess the feasibility of deploying home-based tACS in larger clinical trials, and to prepare for the development and implementation of such trials. The proposed project will systematically examine the feasibility of remote, caregiver-led tACS for older adults who are vulnerable to memory decline. This study will provide data to support the safety and effectiveness of home-based tACS in this population and will lead to future research to increase access of tACS as a part of memory decline prevention and treatment for older adults who have more difficulty reaching a clinic for treatment due to disability or who live more remotely.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial alternating current stimulation (tACS) | tACS will be administered to the left angular gyrus at gamma frequency to improve cognitive functioning (MoCA score) and resting-state EEG signatures. |
Timeline
- Start date
- 2020-07-06
- Primary completion
- 2023-09-30
- Completion
- 2023-09-30
- First posted
- 2021-03-05
- Last updated
- 2024-06-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04783350. Inclusion in this directory is not an endorsement.